Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vaughan

Showing results (251-260 of 1,036) with videos related to

Pageof 104
Sort By:
The Journal of Biological Chemistry|June 25, 1979
Effects of spermine on activity and stability of calcium-dependent guanosine 3',5'-monophosphate phosphodiesteraseR L Kincaid, V C Manganiello, M Vaughan
The Annals of Pharmacotherapy|March 1, 1994
Penetration of intravenous and oral ciprofloxacin into sterile and empyemic human pleural fluidJ Joseph, L M Vaughan, G S Basran
The New England Journal of Medicine|January 20, 1972
Phagocytosis in chronic granulomatous disease and the Chediak-Higashi syndromeT P Stossel, R K Root, M Vaughan
Breast Cancer Research and Treatment|March 17, 2005
The link between the insecticide heptachlor epoxide, estradiol, and breast cancerRichard A Cassidy, Sridhar Natarajan, George M Vaughan
Applied and Environmental Microbiology|April 1, 1990
Chromium(VI)-resistant yeast isolated from a sewage treatment plant receiving tannery wastesF Baldi, A M Vaughan, G J Olson
The Journal of Biological Chemistry|February 25, 1977
Regulation of cyclic nucleotide phosphodiesterases in cultured hepatoma cells by dexamethasone and N6,O2'-dibutyryl adenosine 3':k'-monophosphateP S Ross, V C Manganiello, M Vaughan
Clinical Pharmacology and Therapeutics|April 1, 1987
Stability of theophylline elimination rateG Milavetz, L M Vaughan, M M Weinberger
The Journal of Burn Care & Rehabilitation|May 1, 1985
Hormonal changes following burns: an overview with consideration of the pineal glandG M Vaughan, A D Mason, K Z Shirani
The Journal of Biological Chemistry|March 5, 1993
Characterization of the gene for ADP-ribosylation factor (ARF) 2, a developmentally regulated, selectively expressed member of the ARF family of approximately 20-kDa guanine nucleotide-binding proteinsI M Serventi, E Cavanaugh, J Moss, et al.
The Annals of Pharmacotherapy|April 1, 1992
Alternatives to tetracycline pleurodesisL M Vaughan, P B Walker, S A Sahn
Pageof 104

Showing results (251-260 of 1,036) with videos related to

Sort By:
Pageof 104
The Journal of Biological Chemistry|June 25, 1979
Effects of spermine on activity and stability of calcium-dependent guanosine 3',5'-monophosphate phosphodiesteraseR L Kincaid, V C Manganiello, M Vaughan
The Annals of Pharmacotherapy|March 1, 1994
Penetration of intravenous and oral ciprofloxacin into sterile and empyemic human pleural fluidJ Joseph, L M Vaughan, G S Basran
The New England Journal of Medicine|January 20, 1972
Phagocytosis in chronic granulomatous disease and the Chediak-Higashi syndromeT P Stossel, R K Root, M Vaughan
Breast Cancer Research and Treatment|March 17, 2005
The link between the insecticide heptachlor epoxide, estradiol, and breast cancerRichard A Cassidy, Sridhar Natarajan, George M Vaughan
Applied and Environmental Microbiology|April 1, 1990
Chromium(VI)-resistant yeast isolated from a sewage treatment plant receiving tannery wastesF Baldi, A M Vaughan, G J Olson
The Journal of Biological Chemistry|February 25, 1977
Regulation of cyclic nucleotide phosphodiesterases in cultured hepatoma cells by dexamethasone and N6,O2'-dibutyryl adenosine 3':k'-monophosphateP S Ross, V C Manganiello, M Vaughan
Clinical Pharmacology and Therapeutics|April 1, 1987
Stability of theophylline elimination rateG Milavetz, L M Vaughan, M M Weinberger
The Journal of Burn Care & Rehabilitation|May 1, 1985
Hormonal changes following burns: an overview with consideration of the pineal glandG M Vaughan, A D Mason, K Z Shirani
The Journal of Biological Chemistry|March 5, 1993
Characterization of the gene for ADP-ribosylation factor (ARF) 2, a developmentally regulated, selectively expressed member of the ARF family of approximately 20-kDa guanine nucleotide-binding proteinsI M Serventi, E Cavanaugh, J Moss, et al.
The Annals of Pharmacotherapy|April 1, 1992
Alternatives to tetracycline pleurodesisL M Vaughan, P B Walker, S A Sahn
Pageof 104